Transdermal Drug Delivery System Industry Research Report 2024
Summary
Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
According to APO Research, The global Transdermal Drug Delivery System market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Transdermal Drug Delivery System is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Transdermal Drug Delivery System is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Transdermal Drug Delivery System is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Transdermal Drug Delivery System include Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), Johnson & Johnson, Lohmann, Teikoku Seiyaku and Bayer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Transdermal Drug Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Drug Delivery System.
The Transdermal Drug Delivery System market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transdermal Drug Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Drug Delivery System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transdermal Drug Delivery System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Drug Delivery System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Transdermal Drug Delivery System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
According to APO Research, The global Transdermal Drug Delivery System market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Transdermal Drug Delivery System is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Transdermal Drug Delivery System is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Transdermal Drug Delivery System is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Transdermal Drug Delivery System include Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), Johnson & Johnson, Lohmann, Teikoku Seiyaku and Bayer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Transdermal Drug Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Drug Delivery System.
The Transdermal Drug Delivery System market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transdermal Drug Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Hisamitsu
- Mylan
- GSK
- Novartis
- Teve (Actavis)
- Johnson & Johnson
- Lohmann
- Teikoku Seiyaku
- Bayer
- Lingrui
- Sanofi
- Qizheng
- Endo
- Huarun 999
- Haw Par
- Nichiban
- Mentholatum
- Laboratoires Genevrier
- Fentanyl
- Nitroglycerin
- Estradiol
- Nicotine
- Other
- OTC
- Rx
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Drug Delivery System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transdermal Drug Delivery System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Drug Delivery System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Transdermal Drug Delivery System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Transdermal Drug Delivery System by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Fentanyl
2.2.3 Nitroglycerin
2.2.4 Estradiol
2.2.5 Nicotine
2.2.6 Other
2.3 Transdermal Drug Delivery System by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 OTC
2.3.3 Rx
2.4 Assumptions and Limitations
3 TRANSDERMAL DRUG DELIVERY SYSTEM BREAKDOWN DATA BY TYPE
3.1 Global Transdermal Drug Delivery System Historic Market Size by Type (2019-2024)
3.2 Global Transdermal Drug Delivery System Forecasted Market Size by Type (2025-2030)
4 TRANSDERMAL DRUG DELIVERY SYSTEM BREAKDOWN DATA BY APPLICATION
4.1 Global Transdermal Drug Delivery System Historic Market Size by Application (2019-2024)
4.2 Global Transdermal Drug Delivery System Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Transdermal Drug Delivery System Market Perspective (2019-2030)
5.2 Global Transdermal Drug Delivery System Growth Trends by Region
5.2.1 Global Transdermal Drug Delivery System Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Transdermal Drug Delivery System Historic Market Size by Region (2019-2024)
5.2.3 Transdermal Drug Delivery System Forecasted Market Size by Region (2025-2030)
5.3 Transdermal Drug Delivery System Market Dynamics
5.3.1 Transdermal Drug Delivery System Industry Trends
5.3.2 Transdermal Drug Delivery System Market Drivers
5.3.3 Transdermal Drug Delivery System Market Challenges
5.3.4 Transdermal Drug Delivery System Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Transdermal Drug Delivery System Players by Revenue
6.1.1 Global Top Transdermal Drug Delivery System Players by Revenue (2019-2024)
6.1.2 Global Transdermal Drug Delivery System Revenue Market Share by Players (2019-2024)
6.2 Global Transdermal Drug Delivery System Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Transdermal Drug Delivery System Head office and Area Served
6.4 Global Transdermal Drug Delivery System Players, Product Type & Application
6.5 Global Transdermal Drug Delivery System Players, Date of Enter into This Industry
6.6 Global Transdermal Drug Delivery System Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Transdermal Drug Delivery System Market Size (2019-2030)
7.2 North America Transdermal Drug Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Transdermal Drug Delivery System Market Size by Country (2019-2024)
7.4 North America Transdermal Drug Delivery System Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Transdermal Drug Delivery System Market Size (2019-2030)
8.2 Europe Transdermal Drug Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Transdermal Drug Delivery System Market Size by Country (2019-2024)
8.4 Europe Transdermal Drug Delivery System Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Transdermal Drug Delivery System Market Size (2019-2030)
9.2 Asia-Pacific Transdermal Drug Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Transdermal Drug Delivery System Market Size by Country (2019-2024)
9.4 Asia-Pacific Transdermal Drug Delivery System Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Transdermal Drug Delivery System Market Size (2019-2030)
10.2 Latin America Transdermal Drug Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Transdermal Drug Delivery System Market Size by Country (2019-2024)
10.4 Latin America Transdermal Drug Delivery System Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Transdermal Drug Delivery System Market Size (2019-2030)
11.2 Middle East & Africa Transdermal Drug Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2019-2024)
11.4 Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 Hisamitsu
12.1.1 Hisamitsu Company Information
12.1.2 Hisamitsu Business Overview
12.1.3 Hisamitsu Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.1.4 Hisamitsu Transdermal Drug Delivery System Product Portfolio
12.1.5 Hisamitsu Recent Developments
12.2 Mylan
12.2.1 Mylan Company Information
12.2.2 Mylan Business Overview
12.2.3 Mylan Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.2.4 Mylan Transdermal Drug Delivery System Product Portfolio
12.2.5 Mylan Recent Developments
12.3 GSK
12.3.1 GSK Company Information
12.3.2 GSK Business Overview
12.3.3 GSK Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.3.4 GSK Transdermal Drug Delivery System Product Portfolio
12.3.5 GSK Recent Developments
12.4 Novartis
12.4.1 Novartis Company Information
12.4.2 Novartis Business Overview
12.4.3 Novartis Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.4.4 Novartis Transdermal Drug Delivery System Product Portfolio
12.4.5 Novartis Recent Developments
12.5 Teve (Actavis)
12.5.1 Teve (Actavis) Company Information
12.5.2 Teve (Actavis) Business Overview
12.5.3 Teve (Actavis) Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.5.4 Teve (Actavis) Transdermal Drug Delivery System Product Portfolio
12.5.5 Teve (Actavis) Recent Developments
12.6 Johnson & Johnson
12.6.1 Johnson & Johnson Company Information
12.6.2 Johnson & Johnson Business Overview
12.6.3 Johnson & Johnson Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.6.4 Johnson & Johnson Transdermal Drug Delivery System Product Portfolio
12.6.5 Johnson & Johnson Recent Developments
12.7 Lohmann
12.7.1 Lohmann Company Information
12.7.2 Lohmann Business Overview
12.7.3 Lohmann Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.7.4 Lohmann Transdermal Drug Delivery System Product Portfolio
12.7.5 Lohmann Recent Developments
12.8 Teikoku Seiyaku
12.8.1 Teikoku Seiyaku Company Information
12.8.2 Teikoku Seiyaku Business Overview
12.8.3 Teikoku Seiyaku Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.8.4 Teikoku Seiyaku Transdermal Drug Delivery System Product Portfolio
12.8.5 Teikoku Seiyaku Recent Developments
12.9 Bayer
12.9.1 Bayer Company Information
12.9.2 Bayer Business Overview
12.9.3 Bayer Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.9.4 Bayer Transdermal Drug Delivery System Product Portfolio
12.9.5 Bayer Recent Developments
12.10 Lingrui
12.10.1 Lingrui Company Information
12.10.2 Lingrui Business Overview
12.10.3 Lingrui Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.10.4 Lingrui Transdermal Drug Delivery System Product Portfolio
12.10.5 Lingrui Recent Developments
12.11 Sanofi
12.11.1 Sanofi Company Information
12.11.2 Sanofi Business Overview
12.11.3 Sanofi Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.11.4 Sanofi Transdermal Drug Delivery System Product Portfolio
12.11.5 Sanofi Recent Developments
12.12 Qizheng
12.12.1 Qizheng Company Information
12.12.2 Qizheng Business Overview
12.12.3 Qizheng Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.12.4 Qizheng Transdermal Drug Delivery System Product Portfolio
12.12.5 Qizheng Recent Developments
12.13 Endo
12.13.1 Endo Company Information
12.13.2 Endo Business Overview
12.13.3 Endo Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.13.4 Endo Transdermal Drug Delivery System Product Portfolio
12.13.5 Endo Recent Developments
12.14 Huarun
12.14.1 Huarun 999 Company Information
12.14.2 Huarun 999 Business Overview
12.14.3 Huarun 999 Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.14.4 Huarun 999 Transdermal Drug Delivery System Product Portfolio
12.14.5 Huarun 999 Recent Developments
12.15 Haw Par
12.15.1 Haw Par Company Information
12.15.2 Haw Par Business Overview
12.15.3 Haw Par Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.15.4 Haw Par Transdermal Drug Delivery System Product Portfolio
12.15.5 Haw Par Recent Developments
12.16 Nichiban
12.16.1 Nichiban Company Information
12.16.2 Nichiban Business Overview
12.16.3 Nichiban Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.16.4 Nichiban Transdermal Drug Delivery System Product Portfolio
12.16.5 Nichiban Recent Developments
12.17 Mentholatum
12.17.1 Mentholatum Company Information
12.17.2 Mentholatum Business Overview
12.17.3 Mentholatum Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.17.4 Mentholatum Transdermal Drug Delivery System Product Portfolio
12.17.5 Mentholatum Recent Developments
12.18 Laboratoires Genevrier
12.18.1 Laboratoires Genevrier Company Information
12.18.2 Laboratoires Genevrier Business Overview
12.18.3 Laboratoires Genevrier Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.18.4 Laboratoires Genevrier Transdermal Drug Delivery System Product Portfolio
12.18.5 Laboratoires Genevrier Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Transdermal Drug Delivery System by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Fentanyl
2.2.3 Nitroglycerin
2.2.4 Estradiol
2.2.5 Nicotine
2.2.6 Other
2.3 Transdermal Drug Delivery System by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 OTC
2.3.3 Rx
2.4 Assumptions and Limitations
3 TRANSDERMAL DRUG DELIVERY SYSTEM BREAKDOWN DATA BY TYPE
3.1 Global Transdermal Drug Delivery System Historic Market Size by Type (2019-2024)
3.2 Global Transdermal Drug Delivery System Forecasted Market Size by Type (2025-2030)
4 TRANSDERMAL DRUG DELIVERY SYSTEM BREAKDOWN DATA BY APPLICATION
4.1 Global Transdermal Drug Delivery System Historic Market Size by Application (2019-2024)
4.2 Global Transdermal Drug Delivery System Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Transdermal Drug Delivery System Market Perspective (2019-2030)
5.2 Global Transdermal Drug Delivery System Growth Trends by Region
5.2.1 Global Transdermal Drug Delivery System Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Transdermal Drug Delivery System Historic Market Size by Region (2019-2024)
5.2.3 Transdermal Drug Delivery System Forecasted Market Size by Region (2025-2030)
5.3 Transdermal Drug Delivery System Market Dynamics
5.3.1 Transdermal Drug Delivery System Industry Trends
5.3.2 Transdermal Drug Delivery System Market Drivers
5.3.3 Transdermal Drug Delivery System Market Challenges
5.3.4 Transdermal Drug Delivery System Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Transdermal Drug Delivery System Players by Revenue
6.1.1 Global Top Transdermal Drug Delivery System Players by Revenue (2019-2024)
6.1.2 Global Transdermal Drug Delivery System Revenue Market Share by Players (2019-2024)
6.2 Global Transdermal Drug Delivery System Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Transdermal Drug Delivery System Head office and Area Served
6.4 Global Transdermal Drug Delivery System Players, Product Type & Application
6.5 Global Transdermal Drug Delivery System Players, Date of Enter into This Industry
6.6 Global Transdermal Drug Delivery System Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Transdermal Drug Delivery System Market Size (2019-2030)
7.2 North America Transdermal Drug Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Transdermal Drug Delivery System Market Size by Country (2019-2024)
7.4 North America Transdermal Drug Delivery System Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Transdermal Drug Delivery System Market Size (2019-2030)
8.2 Europe Transdermal Drug Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Transdermal Drug Delivery System Market Size by Country (2019-2024)
8.4 Europe Transdermal Drug Delivery System Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Transdermal Drug Delivery System Market Size (2019-2030)
9.2 Asia-Pacific Transdermal Drug Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Transdermal Drug Delivery System Market Size by Country (2019-2024)
9.4 Asia-Pacific Transdermal Drug Delivery System Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Transdermal Drug Delivery System Market Size (2019-2030)
10.2 Latin America Transdermal Drug Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Transdermal Drug Delivery System Market Size by Country (2019-2024)
10.4 Latin America Transdermal Drug Delivery System Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Transdermal Drug Delivery System Market Size (2019-2030)
11.2 Middle East & Africa Transdermal Drug Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2019-2024)
11.4 Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 Hisamitsu
12.1.1 Hisamitsu Company Information
12.1.2 Hisamitsu Business Overview
12.1.3 Hisamitsu Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.1.4 Hisamitsu Transdermal Drug Delivery System Product Portfolio
12.1.5 Hisamitsu Recent Developments
12.2 Mylan
12.2.1 Mylan Company Information
12.2.2 Mylan Business Overview
12.2.3 Mylan Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.2.4 Mylan Transdermal Drug Delivery System Product Portfolio
12.2.5 Mylan Recent Developments
12.3 GSK
12.3.1 GSK Company Information
12.3.2 GSK Business Overview
12.3.3 GSK Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.3.4 GSK Transdermal Drug Delivery System Product Portfolio
12.3.5 GSK Recent Developments
12.4 Novartis
12.4.1 Novartis Company Information
12.4.2 Novartis Business Overview
12.4.3 Novartis Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.4.4 Novartis Transdermal Drug Delivery System Product Portfolio
12.4.5 Novartis Recent Developments
12.5 Teve (Actavis)
12.5.1 Teve (Actavis) Company Information
12.5.2 Teve (Actavis) Business Overview
12.5.3 Teve (Actavis) Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.5.4 Teve (Actavis) Transdermal Drug Delivery System Product Portfolio
12.5.5 Teve (Actavis) Recent Developments
12.6 Johnson & Johnson
12.6.1 Johnson & Johnson Company Information
12.6.2 Johnson & Johnson Business Overview
12.6.3 Johnson & Johnson Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.6.4 Johnson & Johnson Transdermal Drug Delivery System Product Portfolio
12.6.5 Johnson & Johnson Recent Developments
12.7 Lohmann
12.7.1 Lohmann Company Information
12.7.2 Lohmann Business Overview
12.7.3 Lohmann Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.7.4 Lohmann Transdermal Drug Delivery System Product Portfolio
12.7.5 Lohmann Recent Developments
12.8 Teikoku Seiyaku
12.8.1 Teikoku Seiyaku Company Information
12.8.2 Teikoku Seiyaku Business Overview
12.8.3 Teikoku Seiyaku Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.8.4 Teikoku Seiyaku Transdermal Drug Delivery System Product Portfolio
12.8.5 Teikoku Seiyaku Recent Developments
12.9 Bayer
12.9.1 Bayer Company Information
12.9.2 Bayer Business Overview
12.9.3 Bayer Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.9.4 Bayer Transdermal Drug Delivery System Product Portfolio
12.9.5 Bayer Recent Developments
12.10 Lingrui
12.10.1 Lingrui Company Information
12.10.2 Lingrui Business Overview
12.10.3 Lingrui Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.10.4 Lingrui Transdermal Drug Delivery System Product Portfolio
12.10.5 Lingrui Recent Developments
12.11 Sanofi
12.11.1 Sanofi Company Information
12.11.2 Sanofi Business Overview
12.11.3 Sanofi Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.11.4 Sanofi Transdermal Drug Delivery System Product Portfolio
12.11.5 Sanofi Recent Developments
12.12 Qizheng
12.12.1 Qizheng Company Information
12.12.2 Qizheng Business Overview
12.12.3 Qizheng Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.12.4 Qizheng Transdermal Drug Delivery System Product Portfolio
12.12.5 Qizheng Recent Developments
12.13 Endo
12.13.1 Endo Company Information
12.13.2 Endo Business Overview
12.13.3 Endo Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.13.4 Endo Transdermal Drug Delivery System Product Portfolio
12.13.5 Endo Recent Developments
12.14 Huarun
12.14.1 Huarun 999 Company Information
12.14.2 Huarun 999 Business Overview
12.14.3 Huarun 999 Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.14.4 Huarun 999 Transdermal Drug Delivery System Product Portfolio
12.14.5 Huarun 999 Recent Developments
12.15 Haw Par
12.15.1 Haw Par Company Information
12.15.2 Haw Par Business Overview
12.15.3 Haw Par Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.15.4 Haw Par Transdermal Drug Delivery System Product Portfolio
12.15.5 Haw Par Recent Developments
12.16 Nichiban
12.16.1 Nichiban Company Information
12.16.2 Nichiban Business Overview
12.16.3 Nichiban Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.16.4 Nichiban Transdermal Drug Delivery System Product Portfolio
12.16.5 Nichiban Recent Developments
12.17 Mentholatum
12.17.1 Mentholatum Company Information
12.17.2 Mentholatum Business Overview
12.17.3 Mentholatum Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.17.4 Mentholatum Transdermal Drug Delivery System Product Portfolio
12.17.5 Mentholatum Recent Developments
12.18 Laboratoires Genevrier
12.18.1 Laboratoires Genevrier Company Information
12.18.2 Laboratoires Genevrier Business Overview
12.18.3 Laboratoires Genevrier Revenue in Transdermal Drug Delivery System Business (2019-2024)
12.18.4 Laboratoires Genevrier Transdermal Drug Delivery System Product Portfolio
12.18.5 Laboratoires Genevrier Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Transdermal Drug Delivery System Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Transdermal Drug Delivery System Revenue Market Share by Type (2018-2023)
Table 7. Global Transdermal Drug Delivery System Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Transdermal Drug Delivery System Revenue Market Share by Type (2024-2029)
Table 9. Global Transdermal Drug Delivery System Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Transdermal Drug Delivery System Revenue Market Share by Application (2018-2023)
Table 11. Global Transdermal Drug Delivery System Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Transdermal Drug Delivery System Revenue Market Share by Application (2024-2029)
Table 13. Global Transdermal Drug Delivery System Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Transdermal Drug Delivery System Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Transdermal Drug Delivery System Market Share by Region (2018-2023)
Table 16. Global Transdermal Drug Delivery System Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Transdermal Drug Delivery System Market Share by Region (2024-2029)
Table 18. Transdermal Drug Delivery System Market Trends
Table 19. Transdermal Drug Delivery System Market Drivers
Table 20. Transdermal Drug Delivery System Market Challenges
Table 21. Transdermal Drug Delivery System Market Restraints
Table 22. Global Top Transdermal Drug Delivery System Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Transdermal Drug Delivery System Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Transdermal Drug Delivery System Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Transdermal Drug Delivery System, Headquarters and Area Served
Table 26. Global Transdermal Drug Delivery System Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Transdermal Drug Delivery System by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Transdermal Drug Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Transdermal Drug Delivery System Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Transdermal Drug Delivery System Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Transdermal Drug Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Transdermal Drug Delivery System Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Transdermal Drug Delivery System Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Transdermal Drug Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Transdermal Drug Delivery System Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Transdermal Drug Delivery System Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Transdermal Drug Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Transdermal Drug Delivery System Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Transdermal Drug Delivery System Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Transdermal Drug Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2024-2029) & (US$ Million)
Table 45. Hisamitsu Company Detail
Table 46. Hisamitsu Business Overview
Table 47. Hisamitsu Transdermal Drug Delivery System Product
Table 48. Hisamitsu Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 49. Hisamitsu Recent Development
Table 50. Mylan Company Detail
Table 51. Mylan Business Overview
Table 52. Mylan Transdermal Drug Delivery System Product
Table 53. Mylan Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 54. Mylan Recent Development
Table 55. GSK Company Detail
Table 56. GSK Business Overview
Table 57. GSK Transdermal Drug Delivery System Product
Table 58. GSK Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 59. GSK Recent Development
Table 60. Novartis Company Detail
Table 61. Novartis Business Overview
Table 62. Novartis Transdermal Drug Delivery System Product
Table 63. Novartis Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 64. Novartis Recent Development
Table 65. Teve (Actavis) Company Detail
Table 66. Teve (Actavis) Business Overview
Table 67. Teve (Actavis) Transdermal Drug Delivery System Product
Table 68. Teve (Actavis) Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 69. Teve (Actavis) Recent Development
Table 70. Johnson & Johnson Company Detail
Table 71. Johnson & Johnson Business Overview
Table 72. Johnson & Johnson Transdermal Drug Delivery System Product
Table 73. Johnson & Johnson Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 74. Johnson & Johnson Recent Development
Table 75. Lohmann Company Detail
Table 76. Lohmann Business Overview
Table 77. Lohmann Transdermal Drug Delivery System Product
Table 78. Lohmann Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 79. Lohmann Recent Development
Table 80. Teikoku Seiyaku Company Detail
Table 81. Teikoku Seiyaku Business Overview
Table 82. Teikoku Seiyaku Transdermal Drug Delivery System Product
Table 83. Teikoku Seiyaku Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 84. Teikoku Seiyaku Recent Development
Table 85. Bayer Company Detail
Table 86. Bayer Business Overview
Table 87. Bayer Transdermal Drug Delivery System Product
Table 88. Bayer Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 89. Bayer Recent Development
Table 90. Lingrui Company Detail
Table 91. Lingrui Business Overview
Table 92. Lingrui Transdermal Drug Delivery System Product
Table 93. Lingrui Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 94. Lingrui Recent Development
Table 95. Sanofi Company Detail
Table 96. Sanofi Business Overview
Table 97. Sanofi Transdermal Drug Delivery SystemProduct
Table 98. Sanofi Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 99. Sanofi Recent Development
Table 100. Qizheng Company Detail
Table 101. Qizheng Business Overview
Table 102. Qizheng Transdermal Drug Delivery SystemProduct
Table 103. Qizheng Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 104. Qizheng Recent Development
Table 105. Endo Company Detail
Table 106. Endo Business Overview
Table 107. Endo Transdermal Drug Delivery SystemProduct
Table 108. Endo Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 109. Endo Recent Development
Table 110. Huarun 999 Company Detail
Table 111. Huarun 999 Business Overview
Table 112. Huarun 999 Transdermal Drug Delivery SystemProduct
Table 113. Huarun 999 Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 114. Huarun 999 Recent Development
Table 115. Haw Par Company Detail
Table 116. Haw Par Business Overview
Table 117. Haw Par Transdermal Drug Delivery SystemProduct
Table 118. Haw Par Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 119. Haw Par Recent Development
Table 120. Nichiban Company Detail
Table 121. Nichiban Business Overview
Table 122. Nichiban Transdermal Drug Delivery SystemProduct
Table 123. Nichiban Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 124. Nichiban Recent Development
Table 125. Mentholatum Company Detail
Table 126. Mentholatum Business Overview
Table 127. Mentholatum Transdermal Drug Delivery SystemProduct
Table 128. Mentholatum Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 129. Mentholatum Recent Development
Table 130. Laboratoires Genevrier Company Detail
Table 131. Laboratoires Genevrier Business Overview
Table 132. Laboratoires Genevrier Transdermal Drug Delivery SystemProduct
Table 133. Laboratoires Genevrier Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 134. Laboratoires Genevrier Recent Development
Table 135. Hisamitsu Company Information
Table 136. Hisamitsu Business Overview
Table 137. Hisamitsu Transdermal Drug Delivery System Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 138. Hisamitsu Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 139. Hisamitsu Recent Development
Table 140. Mylan Company Information
Table 141. Mylan Business Overview
Table 142. Mylan Transdermal Drug Delivery System Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 143. Mylan Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 144. Mylan Recent Development
Table 145. GSK Company Information
Table 146. GSK Business Overview
Table 147. GSK Transdermal Drug Delivery System Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 148. GSK Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 149. GSK Recent Development
Table 150. Novartis Company Information
Table 151. Novartis Business Overview
Table 152. Novartis Transdermal Drug Delivery System Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 153. Novartis Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 154. Novartis Recent Development
Table 155. Teve (Actavis) Company Information
Table 156. Teve (Actavis) Business Overview
Table 157. Teve (Actavis) Transdermal Drug Delivery System Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 158. Teve (Actavis) Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 159. Teve (Actavis) Recent Development
Table 160. Johnson & Johnson Company Information
Table 161. Johnson & Johnson Business Overview
Table 162. Johnson & Johnson Transdermal Drug Delivery System Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 163. Johnson & Johnson Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 164. Johnson & Johnson Recent Development
Table 165. Lohmann Company Information
Table 166. Lohmann Business Overview
Table 167. Lohmann Transdermal Drug Delivery System Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 168. Lohmann Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 169. Lohmann Recent Development
Table 170. Teikoku Seiyaku Company Information
Table 171. Teikoku Seiyaku Business Overview
Table 172. Teikoku Seiyaku Transdermal Drug Delivery System Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 173. Teikoku Seiyaku Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 174. Teikoku Seiyaku Recent Development
Table 175. Bayer Company Information
Table 176. Bayer Business Overview
Table 177. Bayer Transdermal Drug Delivery System Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 178. Bayer Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 179. Bayer Recent Development
Table 180. Lingrui Company Information
Table 181. Lingrui Business Overview
Table 182. Lingrui Transdermal Drug Delivery System Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 183. Lingrui Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 184. Lingrui Recent Development
Table 185. Sanofi Company Information
Table 186. Sanofi Business Overview
Table 187. Sanofi Transdermal Drug Delivery SystemRevenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 188. Sanofi Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 189. Sanofi Recent Development
Table 190. Qizheng Company Information
Table 191. Qizheng Business Overview
Table 192. Qizheng Transdermal Drug Delivery SystemRevenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 193. Qizheng Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 194. Qizheng Recent Development
Table 195. Endo Company Information
Table 196. Endo Business Overview
Table 197. Endo Transdermal Drug Delivery SystemRevenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 198. Endo Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 199. Endo Recent Development
Table 200. Huarun 999 Company Information
Table 201. Huarun 999 Business Overview
Table 202. Huarun 999 Transdermal Drug Delivery SystemRevenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 203. Huarun 999 Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 204. Huarun 999 Recent Development
Table 205. Haw Par Company Information
Table 206. Haw Par Business Overview
Table 207. Haw Par Transdermal Drug Delivery SystemRevenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 208. Haw Par Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 209. Haw Par Recent Development
Table 210. Nichiban Company Information
Table 211. Nichiban Business Overview
Table 212. Nichiban Transdermal Drug Delivery SystemRevenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 213. Nichiban Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 214. Nichiban Recent Development
Table 215. Mentholatum Company Information
Table 216. Mentholatum Business Overview
Table 217. Mentholatum Transdermal Drug Delivery SystemRevenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 218. Mentholatum Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 219. Mentholatum Recent Development
Table 220. Laboratoires Genevrier Company Information
Table 221. Laboratoires Genevrier Business Overview
Table 222. Laboratoires Genevrier Transdermal Drug Delivery SystemRevenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 223. Laboratoires Genevrier Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 224. Laboratoires Genevrier Recent Development
Table 225. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Transdermal Drug Delivery System Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Transdermal Drug Delivery System Revenue Market Share by Type (2018-2023)
Table 7. Global Transdermal Drug Delivery System Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Transdermal Drug Delivery System Revenue Market Share by Type (2024-2029)
Table 9. Global Transdermal Drug Delivery System Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Transdermal Drug Delivery System Revenue Market Share by Application (2018-2023)
Table 11. Global Transdermal Drug Delivery System Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Transdermal Drug Delivery System Revenue Market Share by Application (2024-2029)
Table 13. Global Transdermal Drug Delivery System Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Transdermal Drug Delivery System Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Transdermal Drug Delivery System Market Share by Region (2018-2023)
Table 16. Global Transdermal Drug Delivery System Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Transdermal Drug Delivery System Market Share by Region (2024-2029)
Table 18. Transdermal Drug Delivery System Market Trends
Table 19. Transdermal Drug Delivery System Market Drivers
Table 20. Transdermal Drug Delivery System Market Challenges
Table 21. Transdermal Drug Delivery System Market Restraints
Table 22. Global Top Transdermal Drug Delivery System Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Transdermal Drug Delivery System Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Transdermal Drug Delivery System Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Transdermal Drug Delivery System, Headquarters and Area Served
Table 26. Global Transdermal Drug Delivery System Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Transdermal Drug Delivery System by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Transdermal Drug Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Transdermal Drug Delivery System Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Transdermal Drug Delivery System Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Transdermal Drug Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Transdermal Drug Delivery System Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Transdermal Drug Delivery System Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Transdermal Drug Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Transdermal Drug Delivery System Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Transdermal Drug Delivery System Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Transdermal Drug Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Transdermal Drug Delivery System Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Transdermal Drug Delivery System Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Transdermal Drug Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2024-2029) & (US$ Million)
Table 45. Hisamitsu Company Detail
Table 46. Hisamitsu Business Overview
Table 47. Hisamitsu Transdermal Drug Delivery System Product
Table 48. Hisamitsu Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 49. Hisamitsu Recent Development
Table 50. Mylan Company Detail
Table 51. Mylan Business Overview
Table 52. Mylan Transdermal Drug Delivery System Product
Table 53. Mylan Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 54. Mylan Recent Development
Table 55. GSK Company Detail
Table 56. GSK Business Overview
Table 57. GSK Transdermal Drug Delivery System Product
Table 58. GSK Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 59. GSK Recent Development
Table 60. Novartis Company Detail
Table 61. Novartis Business Overview
Table 62. Novartis Transdermal Drug Delivery System Product
Table 63. Novartis Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 64. Novartis Recent Development
Table 65. Teve (Actavis) Company Detail
Table 66. Teve (Actavis) Business Overview
Table 67. Teve (Actavis) Transdermal Drug Delivery System Product
Table 68. Teve (Actavis) Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 69. Teve (Actavis) Recent Development
Table 70. Johnson & Johnson Company Detail
Table 71. Johnson & Johnson Business Overview
Table 72. Johnson & Johnson Transdermal Drug Delivery System Product
Table 73. Johnson & Johnson Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 74. Johnson & Johnson Recent Development
Table 75. Lohmann Company Detail
Table 76. Lohmann Business Overview
Table 77. Lohmann Transdermal Drug Delivery System Product
Table 78. Lohmann Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 79. Lohmann Recent Development
Table 80. Teikoku Seiyaku Company Detail
Table 81. Teikoku Seiyaku Business Overview
Table 82. Teikoku Seiyaku Transdermal Drug Delivery System Product
Table 83. Teikoku Seiyaku Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 84. Teikoku Seiyaku Recent Development
Table 85. Bayer Company Detail
Table 86. Bayer Business Overview
Table 87. Bayer Transdermal Drug Delivery System Product
Table 88. Bayer Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 89. Bayer Recent Development
Table 90. Lingrui Company Detail
Table 91. Lingrui Business Overview
Table 92. Lingrui Transdermal Drug Delivery System Product
Table 93. Lingrui Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 94. Lingrui Recent Development
Table 95. Sanofi Company Detail
Table 96. Sanofi Business Overview
Table 97. Sanofi Transdermal Drug Delivery SystemProduct
Table 98. Sanofi Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 99. Sanofi Recent Development
Table 100. Qizheng Company Detail
Table 101. Qizheng Business Overview
Table 102. Qizheng Transdermal Drug Delivery SystemProduct
Table 103. Qizheng Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 104. Qizheng Recent Development
Table 105. Endo Company Detail
Table 106. Endo Business Overview
Table 107. Endo Transdermal Drug Delivery SystemProduct
Table 108. Endo Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 109. Endo Recent Development
Table 110. Huarun 999 Company Detail
Table 111. Huarun 999 Business Overview
Table 112. Huarun 999 Transdermal Drug Delivery SystemProduct
Table 113. Huarun 999 Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 114. Huarun 999 Recent Development
Table 115. Haw Par Company Detail
Table 116. Haw Par Business Overview
Table 117. Haw Par Transdermal Drug Delivery SystemProduct
Table 118. Haw Par Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 119. Haw Par Recent Development
Table 120. Nichiban Company Detail
Table 121. Nichiban Business Overview
Table 122. Nichiban Transdermal Drug Delivery SystemProduct
Table 123. Nichiban Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 124. Nichiban Recent Development
Table 125. Mentholatum Company Detail
Table 126. Mentholatum Business Overview
Table 127. Mentholatum Transdermal Drug Delivery SystemProduct
Table 128. Mentholatum Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 129. Mentholatum Recent Development
Table 130. Laboratoires Genevrier Company Detail
Table 131. Laboratoires Genevrier Business Overview
Table 132. Laboratoires Genevrier Transdermal Drug Delivery SystemProduct
Table 133. Laboratoires Genevrier Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 134. Laboratoires Genevrier Recent Development
Table 135. Hisamitsu Company Information
Table 136. Hisamitsu Business Overview
Table 137. Hisamitsu Transdermal Drug Delivery System Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 138. Hisamitsu Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 139. Hisamitsu Recent Development
Table 140. Mylan Company Information
Table 141. Mylan Business Overview
Table 142. Mylan Transdermal Drug Delivery System Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 143. Mylan Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 144. Mylan Recent Development
Table 145. GSK Company Information
Table 146. GSK Business Overview
Table 147. GSK Transdermal Drug Delivery System Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 148. GSK Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 149. GSK Recent Development
Table 150. Novartis Company Information
Table 151. Novartis Business Overview
Table 152. Novartis Transdermal Drug Delivery System Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 153. Novartis Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 154. Novartis Recent Development
Table 155. Teve (Actavis) Company Information
Table 156. Teve (Actavis) Business Overview
Table 157. Teve (Actavis) Transdermal Drug Delivery System Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 158. Teve (Actavis) Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 159. Teve (Actavis) Recent Development
Table 160. Johnson & Johnson Company Information
Table 161. Johnson & Johnson Business Overview
Table 162. Johnson & Johnson Transdermal Drug Delivery System Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 163. Johnson & Johnson Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 164. Johnson & Johnson Recent Development
Table 165. Lohmann Company Information
Table 166. Lohmann Business Overview
Table 167. Lohmann Transdermal Drug Delivery System Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 168. Lohmann Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 169. Lohmann Recent Development
Table 170. Teikoku Seiyaku Company Information
Table 171. Teikoku Seiyaku Business Overview
Table 172. Teikoku Seiyaku Transdermal Drug Delivery System Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 173. Teikoku Seiyaku Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 174. Teikoku Seiyaku Recent Development
Table 175. Bayer Company Information
Table 176. Bayer Business Overview
Table 177. Bayer Transdermal Drug Delivery System Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 178. Bayer Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 179. Bayer Recent Development
Table 180. Lingrui Company Information
Table 181. Lingrui Business Overview
Table 182. Lingrui Transdermal Drug Delivery System Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 183. Lingrui Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 184. Lingrui Recent Development
Table 185. Sanofi Company Information
Table 186. Sanofi Business Overview
Table 187. Sanofi Transdermal Drug Delivery SystemRevenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 188. Sanofi Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 189. Sanofi Recent Development
Table 190. Qizheng Company Information
Table 191. Qizheng Business Overview
Table 192. Qizheng Transdermal Drug Delivery SystemRevenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 193. Qizheng Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 194. Qizheng Recent Development
Table 195. Endo Company Information
Table 196. Endo Business Overview
Table 197. Endo Transdermal Drug Delivery SystemRevenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 198. Endo Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 199. Endo Recent Development
Table 200. Huarun 999 Company Information
Table 201. Huarun 999 Business Overview
Table 202. Huarun 999 Transdermal Drug Delivery SystemRevenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 203. Huarun 999 Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 204. Huarun 999 Recent Development
Table 205. Haw Par Company Information
Table 206. Haw Par Business Overview
Table 207. Haw Par Transdermal Drug Delivery SystemRevenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 208. Haw Par Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 209. Haw Par Recent Development
Table 210. Nichiban Company Information
Table 211. Nichiban Business Overview
Table 212. Nichiban Transdermal Drug Delivery SystemRevenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 213. Nichiban Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 214. Nichiban Recent Development
Table 215. Mentholatum Company Information
Table 216. Mentholatum Business Overview
Table 217. Mentholatum Transdermal Drug Delivery SystemRevenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 218. Mentholatum Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 219. Mentholatum Recent Development
Table 220. Laboratoires Genevrier Company Information
Table 221. Laboratoires Genevrier Business Overview
Table 222. Laboratoires Genevrier Transdermal Drug Delivery SystemRevenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million)
Table 223. Laboratoires Genevrier Revenue in Transdermal Drug Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 224. Laboratoires Genevrier Recent Development
Table 225. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Transdermal Drug Delivery System Product Picture
Figure 5. Global Transdermal Drug Delivery System Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Transdermal Drug Delivery System Market Share by Type: 2022 VS 2029
Figure 7. Fentanyl Product Picture
Figure 8. Nitroglycerin Product Picture
Figure 9. Estradiol Product Picture
Figure 10. Nicotine Product Picture
Figure 11. Other Product Picture
Figure 12. Global Transdermal Drug Delivery System Market Size by Application (2023-2029) & (US$ Million)
Figure 13. Global Transdermal Drug Delivery System Market Share by Application: 2022 VS 2029
Figure 14. OTC Product Picture
Figure 15. Rx Product Picture
Figure 16. Global Transdermal Drug Delivery System Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 17. Global Transdermal Drug Delivery System Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Transdermal Drug Delivery System Market Share by Region: 2022 VS 2029
Figure 19. Global Transdermal Drug Delivery System Market Share by Players in 2022
Figure 20. Global Transdermal Drug Delivery System Players, Date of Enter into This Industry
Figure 21. Global Top 5 and 10 Transdermal Drug Delivery System Players Market Share by Revenue in 2022
Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 23. North America Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. North America Transdermal Drug Delivery System Market Share by Country (2018-2029)
Figure 25. United States Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Transdermal Drug Delivery System Market Share by Country (2018-2029)
Figure 29. Germany Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific Transdermal Drug Delivery System Market Share by Country (2018-2029)
Figure 37. China Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Japan Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. South Korea Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. India Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Australia Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America Transdermal Drug Delivery System Market Share by Country (2018-2029)
Figure 45. Mexico Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Brazil Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Transdermal Drug Delivery System Market Share by Country (2018-2029)
Figure 49. Turkey Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. UAE Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Hisamitsu Revenue Growth Rate in Transdermal Drug Delivery System Business (2018-2023)
Figure 53. Mylan Revenue Growth Rate in Transdermal Drug Delivery System Business (2018-2023)
Figure 54. GSK Revenue Growth Rate in Transdermal Drug Delivery System Business (2018-2023)
Figure 55. Novartis Revenue Growth Rate in Transdermal Drug Delivery System Business (2018-2023)
Figure 56. Teve (Actavis) Revenue Growth Rate in Transdermal Drug Delivery System Business (2018-2023)
Figure 57. Johnson & Johnson Revenue Growth Rate in Transdermal Drug Delivery System Business (2018-2023)
Figure 58. Lohmann Revenue Growth Rate in Transdermal Drug Delivery System Business (2018-202
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Transdermal Drug Delivery System Product Picture
Figure 5. Global Transdermal Drug Delivery System Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Transdermal Drug Delivery System Market Share by Type: 2022 VS 2029
Figure 7. Fentanyl Product Picture
Figure 8. Nitroglycerin Product Picture
Figure 9. Estradiol Product Picture
Figure 10. Nicotine Product Picture
Figure 11. Other Product Picture
Figure 12. Global Transdermal Drug Delivery System Market Size by Application (2023-2029) & (US$ Million)
Figure 13. Global Transdermal Drug Delivery System Market Share by Application: 2022 VS 2029
Figure 14. OTC Product Picture
Figure 15. Rx Product Picture
Figure 16. Global Transdermal Drug Delivery System Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 17. Global Transdermal Drug Delivery System Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Transdermal Drug Delivery System Market Share by Region: 2022 VS 2029
Figure 19. Global Transdermal Drug Delivery System Market Share by Players in 2022
Figure 20. Global Transdermal Drug Delivery System Players, Date of Enter into This Industry
Figure 21. Global Top 5 and 10 Transdermal Drug Delivery System Players Market Share by Revenue in 2022
Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 23. North America Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. North America Transdermal Drug Delivery System Market Share by Country (2018-2029)
Figure 25. United States Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Transdermal Drug Delivery System Market Share by Country (2018-2029)
Figure 29. Germany Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific Transdermal Drug Delivery System Market Share by Country (2018-2029)
Figure 37. China Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Japan Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. South Korea Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. India Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Australia Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America Transdermal Drug Delivery System Market Share by Country (2018-2029)
Figure 45. Mexico Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Brazil Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Transdermal Drug Delivery System Market Share by Country (2018-2029)
Figure 49. Turkey Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. UAE Transdermal Drug Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Hisamitsu Revenue Growth Rate in Transdermal Drug Delivery System Business (2018-2023)
Figure 53. Mylan Revenue Growth Rate in Transdermal Drug Delivery System Business (2018-2023)
Figure 54. GSK Revenue Growth Rate in Transdermal Drug Delivery System Business (2018-2023)
Figure 55. Novartis Revenue Growth Rate in Transdermal Drug Delivery System Business (2018-2023)
Figure 56. Teve (Actavis) Revenue Growth Rate in Transdermal Drug Delivery System Business (2018-2023)
Figure 57. Johnson & Johnson Revenue Growth Rate in Transdermal Drug Delivery System Business (2018-2023)
Figure 58. Lohmann Revenue Growth Rate in Transdermal Drug Delivery System Business (2018-202
